MeSH tree: D20.215.894.899.050
A new HIV vaccine developed by La Jolla Institute for Immunology (LJI), Scripps Research scientists and IAVI has the potential to protect humans from developing HIV infection and AIDS. This HIV vaccine is the first to generate ...
Jul 6, 2026
0
42
In the early 1990s, a secret HIV vaccine research project was carried out in the Central African Republic. The project didn't yield results and was hidden for many years. Today it sheds light on debates over clinical trials, ...
May 1, 2026
0
6
Some people living with HIV develop antibodies capable of neutralizing many different strains of the virus. New research links this to immune responses that occur early in infection. The findings, published in PLOS Pathogens, ...
Apr 21, 2026
0
11
One of the biggest hurdles in developing an HIV vaccine is coaxing the body to produce the right kind of immune cells and antibodies. In most vaccines, HIV proteins are attached to a larger protein scaffolding that mimics ...
Feb 5, 2026
0
18
Scientists at The Wistar Institute have developed an HIV vaccine candidate that achieves something never before observed in the field: inducing neutralizing antibodies against HIV after a single immunization in nonhuman primates. ...
Feb 3, 2026
0
163
Just a week had remained before scientists in South Africa were to begin clinical trials of an HIV vaccine, and hopes were high for another step toward limiting one of history's deadliest pandemics. Then the email arrived.
Jul 13, 2025
0
14
The Trump administration's cuts to funding for scientific research have left many scientists reeling and very worried. At the National Institutes of Health in the US, which has an annual budget of US$47 billion to support ...
May 12, 2025
0
15
Many vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system will produce long-lasting antibodies recognizing that specific virus, thereby providing protection.
Jan 17, 2025
0
155
Researchers at the Duke Human Vaccine Institute successfully created an HIV vaccine candidate that guides key immune cells along an evolutionary pathway to become broadly neutralizing antibodies.
Jan 15, 2025
0
103
HIV remains a major global public health challenge.
Dec 2, 2024
0
22
